Akari Therapeutics Stock (NASDAQ: AKTX) stock price, news, charts, stock research, profile.
Open | $3.15 |
Close | $3.22 |
Volume / Avg. | 617.00 / 18.24K |
Day Range | $3.15 - $3.22 |
52 Wk Range | 1.08 - 4.40 |
Market Cap | $38.26M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 0.41% |
Days to Cover | 1.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Akari Therapeutics (NASDAQ:AKTX) through any online brokerage.
Other companies in Akari Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX) and Gain Therapeutics (NASDAQ:GANX).
Akari Therapeutics has a consensus price target of $2.75.
The stock price for Akari Therapeutics (NASDAQ: AKTX) is $3.15 last updated September 13, 2024 at 4:52 PM EDT.
There are no upcoming dividends for Akari Therapeutics.
Akari Therapeutics’s Q3 earnings are confirmed for Tuesday, November 19, 2024.
There is no upcoming split for Akari Therapeutics.
Akari Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.